Cathy Friedman - Dec 14, 2021 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Role
Director
Signature
/s/ Heather Turner, as Attorney-in-Fact
Stock symbol
LYEL
Transactions as of
Dec 14, 2021
Transactions value $
$0
Form type
4
Date filed
12/14/2021, 03:57 PM
Previous filing
Jun 23, 2021
Next filing
Jan 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYEL Common Stock Other $0 -3.77M -100% $0.00* 0 Dec 14, 2021 Lyell Investors, LLC F1
transaction LYEL Common Stock Other $0 +219K +1239.36% $0.00 236K Dec 14, 2021 MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST F2
holding LYEL Common Stock 100K Dec 14, 2021 The Duane Irrevocable Trust 2020 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro-rata distribution by Lyell Investors, LLC to its members.
F2 Received in a pro-rata distribution from Lyell Investors, LLC. The Reporting Person is a trustee of MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST ("Duane Family Trust") and therefore may be deemed to share the power to direct the disposition and vote of the shares held by the Duane Family Trust. The Reporting Person disclaims beneficial ownership of all shares held by Duane Family Trust except to any pecuniary interest therein.
F3 The Reporting Person is a trustee of The Duane Irrevocable Trust 2020 ("Duane Irrevocable Trust") and therefore may be deemed to share the power to direct the disposition and vote of the shares held by the Duane Irrevocable Trust. The Reporting Person disclaims beneficial ownership of all shares held by Duane Irrevocable Trust except to any pecuniary interest therein.